Google wins appeal of $20 million US patent verdict over Chrome technology

By Blake Brittain (Reuters) – Alphabet’s Google LLC on Tuesday convinced a U.S. appeals court to cancel three anti-malware patents at the heart of a Texas jury’s $20 million infringement verdict against the company. The U.S. Court of Appeals for the Federal Circuit said that Alfonso Cioffi and Allen Rozman’s patents were invalid because they…

Read More

AstraZeneca confident new COVID antibody protects against known variants

By Maggie Fick BARCELONA (Reuters) – AstraZeneca is confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants, its vaccines head said. Laboratory studies show the antibody, called AZD3152, neutralizes all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by…

Read More

Despite SVB collapse, FDIC on track to recoup insurance losses: Chair

(Reuters) – Despite the second- and third-largest bank failures in U.S. history last month, the U.S. Federal Deposit Insurance Corporation remains on track to refill its deposit insurance fund ahead of a 2028 legal deadline, the head of the agency said Tuesday. At a public meeting of the Federal Deposit Insurance Corporation, Chairman Martin Gruenberg…

Read More

Once-dominant foreign auto brands pledge comeback in China

SHANGHAI (Reuters) -Global automakers, including Toyota and Volkswagen, took the stage at the Shanghai auto show on Tuesday with built-for-China and electric-drive products to compete for a high-stakes comeback in the world’s largest market. But after a year when trends have shifted sharply against the established foreign brands that once dominated in China, executives from…

Read More

Lockheed Martin taps strong defense demand to beat results estimates

By Mike Stone and Shivansh Tiwary (Reuters) -U.S. weapons maker Lockheed Martin Corp’s first-quarter results surpassed Wall Street targets on Tuesday despite parts and labor shortages, as simmering geopolitical tensions fueled demand from both U.S. and international customers. Shares of the company rose as much as 3.8% to hit a record high of $508.1 in…

Read More

GSK bets $2 billion on Bellus cough drug to soothe pipeline fears

By Natalie Grover and Aby Jose Koilparambil (Reuters) -GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish its pipeline comes as GSK investors fret about whether there is enough in the medicine cabinet…

Read More

UK regulator probes Amazon’s planned purchase of iRobot

(Reuters) -Britain’s competition regulator said on Tuesday it has launched a “Phase 1” probe into Amazon.com Inc’s planned $1.7 billion acquisition of iRobot Corp, which makes the Roomba vacuum cleaner. The probe launch by the UK watchdog comes at a time antitrust regulators, including those in the U.S. and the European Union, have become increasingly…

Read More